58 related articles for article (PubMed ID: 2607655)
1. [A new role of uric acid as an antioxidant in human plasma].
Hasegawa T; Kuroda M
Rinsho Byori; 1989 Sep; 37(9):1020-7. PubMed ID: 2607655
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of vitamin E metabolites in the blood of renal failure patients.
Galli F; Floridi AG; Floridi A; Buoncristiani U
Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of allantoin, hypoxanthine, xanthine, and uric acid in serum/plasma by CE.
Caussé E; Pradelles A; Dirat B; Negre-Salvayre A; Salvayre R; Couderc F
Electrophoresis; 2007 Feb; 28(3):381-7. PubMed ID: 17177243
[TBL] [Abstract][Full Text] [Related]
4. Global assessment of serum antioxidant status in hemodialysis patients.
Mircescu G; Capuşă C; Stoian I; Vârgolici B; Barbulescu C; Ursea N
J Nephrol; 2005; 18(5):599-605. PubMed ID: 16299688
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of antioxidant properties of uric acid in humans for a consideration measuring of levels of allantoin in plasma by liquid chromatography.
Kand'ár R; Záková P; Muzáková V
Clin Chim Acta; 2006 Mar; 365(1-2):249-56. PubMed ID: 16194528
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis.
Hultqvist M; Hegbrant J; Nilsson-Thorell C; Lindholm T; Nilsson P; Lindén T; Hultqvist-Bengtsson U
Clin Nephrol; 1997 Jan; 47(1):37-46. PubMed ID: 9021240
[TBL] [Abstract][Full Text] [Related]
7. [A study on plasma allantoin in patients undergoing maintenance hemodialysis].
Motomiya Y; Sasaki K; Okajima E; Uji Y; Okabe H
Nihon Jinzo Gakkai Shi; 1993 Jul; 35(7):853-8. PubMed ID: 8411765
[TBL] [Abstract][Full Text] [Related]
8. Changes in conjugated linoleic acid and palmitoleic acid are correlated to retinol levels in chronic renal failure in both hemodialysis and conservative treatment patients.
Lucchi L; Banni S; Iannone A; Melis MP; Carta G; Murru E; Cordeddu L; Stipo L; Uggeri S; Gatti V; Malaguti V; Albertazzi A
Artif Organs; 2005 May; 29(5):413-8. PubMed ID: 15854218
[TBL] [Abstract][Full Text] [Related]
9. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
[TBL] [Abstract][Full Text] [Related]
10. Hereditary nephropathy associated with hyperuricemia and gout.
Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress in elderly chronic renal failure patients: effects of renal replacement therapies on cell membrane fluidity.
Goi G; Massaccesi L; Baquero Herrera CJ; Musetti C; Ciurlino D; Cusi D; Bertoli S
J Nephrol; 2009; 22(5):630-6. PubMed ID: 19809996
[TBL] [Abstract][Full Text] [Related]
12. Changes in plasma concentrations of hypoxanthine and uric acid before and after hemodialysis.
Shahbazian H; Zand Moghadam A; Ehsanpour A; Khazaali M
Iran J Kidney Dis; 2009 Jul; 3(3):151-5. PubMed ID: 19617664
[TBL] [Abstract][Full Text] [Related]
13. Effects of diabetes mellitus, chronic renal failure and hemodialysis on serum and salivary antioxidant status.
Ben-Zvi I; Green Y; Nakhoul F; Kanter Y; Nagler RM
Nephron Clin Pract; 2007; 105(3):c114-20. PubMed ID: 17199094
[TBL] [Abstract][Full Text] [Related]
14. Influence of antioxidants (mannitol and allopurinol) on oxygen free radical generation during and after cardiopulmonary bypass.
England MD; Cavarocchi NC; O'Brien JF; Solis E; Pluth JR; Orszulak TA; Kaye MP; Schaff HV
Circulation; 1986 Nov; 74(5 Pt 2):III134-7. PubMed ID: 3094981
[TBL] [Abstract][Full Text] [Related]
15. Phagocyte-derived oxidants and plasma antioxidants in haemodialysed patients.
Soska V; Ciz M; Kubala L; Sobotova D; Lojek A
Scand J Clin Lab Invest; 2007; 67(3):343-51. PubMed ID: 17454849
[TBL] [Abstract][Full Text] [Related]
16. Uric acid and allantoin levels in Down syndrome: antioxidant and oxidative stress mechanisms?
Zitnanová I; Korytár P; Aruoma OI; Sustrová M; Garaiová I; Muchová J; Kalnovicová T; Pueschel S; Duracková Z
Clin Chim Acta; 2004 Mar; 341(1-2):139-46. PubMed ID: 14967170
[TBL] [Abstract][Full Text] [Related]
17. Novel hydroxyl radical scavenging antioxidant activity assay for water-soluble antioxidants using a modified CUPRAC method.
Bektaşoğlu B; Esin Celik S; Ozyürek M; Güçlü K; Apak R
Biochem Biophys Res Commun; 2006 Jul; 345(3):1194-200. PubMed ID: 16716257
[TBL] [Abstract][Full Text] [Related]
18. Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients.
Clermont G; Lecour S; Lahet J; Siohan P; Vergely C; Chevet D; Rifle G; Rochette L
Cardiovasc Res; 2000 Aug; 47(3):618-23. PubMed ID: 10963735
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyl radical scavenging assay of phenolics and flavonoids with a modified cupric reducing antioxidant capacity (CUPRAC) method using catalase for hydrogen peroxide degradation.
Ozyürek M; Bektaşoğlu B; Güçlü K; Apak R
Anal Chim Acta; 2008 Jun; 616(2):196-206. PubMed ID: 18482604
[TBL] [Abstract][Full Text] [Related]
20. Purine bases and atheromatous plaque.
Terzuoli L; Marinello E; Felici C; Frosi B; Setacci C; Giubbolini M; Porcelli B
Int J Immunopathol Pharmacol; 2004; 17(3 Suppl):31-3. PubMed ID: 16857104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
